Related Experiment Videos
'Classic' and 'acute' myelofibrosis. A retrospective study
Acta Haematologica
|January 1, 1978
Summary
Predicting myelofibrosis progression is possible using initial patient data. Key indicators like reticulocyte counts and serum LDH levels can differentiate between acute and classic fibrosis development.
Area of Science:
- Hematology
- Oncology
Background:
- Myelofibrosis is a serious myeloproliferative neoplasm.
- Predicting the disease course is crucial for patient management.
Purpose of the Study:
- To identify early predictors of myelofibrosis progression.
- To differentiate between acute and classic myelofibrosis development.
Main Methods:
- Retrospective analysis of 38 patients with histologically proven myelofibrosis.
- Evaluation of five parameters on initial admission: pancytopenia, reticulocyte counts, serum LDH, uric acid, and SRE.
Main Results:
- Acute myelofibrosis development predicted by pancytopenia, low reticulocyte counts, extremely elevated SRE, and normal LDH/uric acid.
- Classic fibrosis with splenomegaly predicted by high reticulocyte counts and elevated LDH/uric acid, even without initial splenomegaly.
Conclusions:
- Initial clinical and laboratory parameters can predict myelofibrosis disease course.
- Distinctive patterns of reticulocyte counts, LDH, and uric acid levels differentiate acute from classic myelofibrosis.